Skip to main content
Erschienen in: Archives of Virology 2/2009

01.02.2009 | Original Article

HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9

verfasst von: Kozaburo Hayashi, Laura C. Hooper, Barbara Detrick, John J. Hooks

Erschienen in: Archives of Virology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Angiogenesis and inflammatory mediators are critical pathogenic factors in herpetic stromal keratitis (HSK). Since disease progresses without infectious virus, HSV-DNA and HSV-IgG complexes (HSV-IC) may contribute to HSK by triggering these factors. Production of VEGF and MMP-9 was studied in vitro using corneal epithelial cells (HCE), fibroblasts (HCRF) and macrophages (THP-1). VEGF was elevated in HCRF and THP-1 following treatment with HSV-DNA and HSV-IC. MMP-9 was elevated in THP-1 but not in corneal cells. When anti-HSV-IgG(Fab′)2 complexes stimulated THP-1, MMP-9 was reduced to control levels. Pretreatment of THP-1 with anti-TLR-2 and -3 inhibited MMP-9 production. Thus, HSV-IC may stimulate THP-1 through the Fc receptor and TLRs. Proinflammatory cytokines (IL-1b, IL-6, and TNF-α) increased VEGF and MMP-9 in corneal cells and macrophages. These studies indicate that the continued presence of HSV-DNA and HSV-IC contribute to angiogenesis and inflammation in HSK. Thus, cytokines and TLRs may be potential targets for intervention.
Literatur
1.
Zurück zum Zitat Akira S, Takeda K (2004) Toll like receptor signaling. Nat Rev Immunol 4:499–511PubMed Akira S, Takeda K (2004) Toll like receptor signaling. Nat Rev Immunol 4:499–511PubMed
2.
Zurück zum Zitat Akira S, Uematsu S et al (2006) Pathogen recognition and innate immunity. Cell 124:783–880PubMed Akira S, Uematsu S et al (2006) Pathogen recognition and innate immunity. Cell 124:783–880PubMed
3.
Zurück zum Zitat Banerjee K, Biswas PS et al (2005) Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukocyte Biol 77:24–32PubMed Banerjee K, Biswas PS et al (2005) Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukocyte Biol 77:24–32PubMed
4.
Zurück zum Zitat Biswas PS, Banerjee K et al (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMed Biswas PS, Banerjee K et al (2006) Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res 82:46–54PubMed
5.
Zurück zum Zitat Biswas PS, Rouse BT (2005) Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7:799–810PubMed Biswas PS, Rouse BT (2005) Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7:799–810PubMed
6.
Zurück zum Zitat Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014–1018PubMed Blander JM, Medzhitov R (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304:1014–1018PubMed
7.
Zurück zum Zitat Blander JM (2007) Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 28:19–25PubMed Blander JM (2007) Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 28:19–25PubMed
8.
Zurück zum Zitat Cox D, Tseng CC et al (1997) A requirement for phosphoinositol 3-kinase in pseodopod extension. J Biol Chem 274:1240–1247 Cox D, Tseng CC et al (1997) A requirement for phosphoinositol 3-kinase in pseodopod extension. J Biol Chem 274:1240–1247
9.
Zurück zum Zitat Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1(HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMed Hayashi K, Hooper LC et al (2006) Herpes simplex virus 1(HSV-1) DNA and immune complex (HSV-1-human IgG) elicit vigorous interleukin 6 release from infected corneal cells via Toll-like receptors. J Gen Virol 87:2161–2169PubMed
10.
Zurück zum Zitat Kwong AD, Kruper JA et al (1988) Herpes simplex virus virion host shut off function. J Virol 62:912–921PubMed Kwong AD, Kruper JA et al (1988) Herpes simplex virus virion host shut off function. J Virol 62:912–921PubMed
11.
Zurück zum Zitat Lee S, Zheng M et al (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105–1111PubMed Lee S, Zheng M et al (2002) Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest 110:1105–1111PubMed
12.
Zurück zum Zitat Li X, Tupper JC et al (2003) Phosphoinositide-3 kinase mediate Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 71:4414–4420PubMed Li X, Tupper JC et al (2003) Phosphoinositide-3 kinase mediate Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells. Infect Immun 71:4414–4420PubMed
13.
Zurück zum Zitat Liesengang TS (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1–13 Liesengang TS (2001) Herpes simplex virus epidemiology and ocular importance. Cornea 20:1–13
14.
Zurück zum Zitat Matsumoto M, Kikkawa S et al (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369PubMed Matsumoto M, Kikkawa S et al (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369PubMed
15.
Zurück zum Zitat Meyers-Elliott RH, Pettit TH et al (1980) Viral antigens in the immune ring of herpes simplex stromal keratits. Arch Ophthalmol 98:897–904PubMed Meyers-Elliott RH, Pettit TH et al (1980) Viral antigens in the immune ring of herpes simplex stromal keratits. Arch Ophthalmol 98:897–904PubMed
16.
Zurück zum Zitat Opremcak EM, Rice BA et al (1990) Histology and immunohistology of Ig-h-1-restricted herpes simplex keratitisin Balb/c congenic mice. Invest Ophthalmol Vis Sci 31:305–312PubMed Opremcak EM, Rice BA et al (1990) Histology and immunohistology of Ig-h-1-restricted herpes simplex keratitisin Balb/c congenic mice. Invest Ophthalmol Vis Sci 31:305–312PubMed
17.
Zurück zum Zitat Sciortino M-T, Suzuki M et al (2001) RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol 75:8105–8116PubMed Sciortino M-T, Suzuki M et al (2001) RNAs extracted from herpes simplex virus 1 virions: apparent selectivity of viral but not cellular RNAs packaged in virions. J Virol 75:8105–8116PubMed
18.
Zurück zum Zitat Sarkar SN, Peters KL et al (2004) Novel roles of TLR3 tyrosine phosphorylation and PI Kinase in double strand RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMed Sarkar SN, Peters KL et al (2004) Novel roles of TLR3 tyrosine phosphorylation and PI Kinase in double strand RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMed
19.
Zurück zum Zitat Shimomura Y, Deai T et al (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMed Shimomura Y, Deai T et al (2007) Corneal buttons obtained from HSK patients harbor high copy number of the HSV genome. Cornea 26:190–193PubMed
20.
Zurück zum Zitat Staats HF, Lausch RN (1993) Cytokine expression in vivo during murine herpetic stromal keratits. Effect of protective antibody therapy. J Immunol 151:277–283PubMed Staats HF, Lausch RN (1993) Cytokine expression in vivo during murine herpetic stromal keratits. Effect of protective antibody therapy. J Immunol 151:277–283PubMed
21.
Zurück zum Zitat Toker A, Cantley LC (1997) Signaling through the lipid products of phosphoinositide-3-OH-kinase. Nature 387:673–676PubMed Toker A, Cantley LC (1997) Signaling through the lipid products of phosphoinositide-3-OH-kinase. Nature 387:673–676PubMed
22.
Zurück zum Zitat Tsuchiya S, Kobayashi Y et al (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530–1536PubMed Tsuchiya S, Kobayashi Y et al (1982) Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 42:1530–1536PubMed
23.
Zurück zum Zitat Ueta M, Hamuro J et al (2005) Triggering of TLR3 by poly I:C in human corneal epithelial cells to induce inflammatory cytopkines. Biochem Biophys Res Commun 331:285–294PubMed Ueta M, Hamuro J et al (2005) Triggering of TLR3 by poly I:C in human corneal epithelial cells to induce inflammatory cytopkines. Biochem Biophys Res Commun 331:285–294PubMed
24.
Zurück zum Zitat Underhill DM, Gantner B (2004) Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 6:1368–1373PubMed Underhill DM, Gantner B (2004) Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 6:1368–1373PubMed
25.
Zurück zum Zitat Underhill DM, Ozinsky A et al (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811–815PubMed Underhill DM, Ozinsky A et al (1999) The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811–815PubMed
26.
Zurück zum Zitat Viahos CJ, Matter WF et al (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8 phenyl-4H-I-benzopyran-4-one (LY294002). J Boiol Chem 269:5241–5248 Viahos CJ, Matter WF et al (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8 phenyl-4H-I-benzopyran-4-one (LY294002). J Boiol Chem 269:5241–5248
27.
Zurück zum Zitat Yang Y-N, Bauer D et al (2003) Matrix metalloproteases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res 77:227–237PubMed Yang Y-N, Bauer D et al (2003) Matrix metalloproteases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp Eye Res 77:227–237PubMed
28.
Zurück zum Zitat Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocutes in response to microbes, their products, and cytokines. J Immunol 168:554–561PubMed Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocutes in response to microbes, their products, and cytokines. J Immunol 168:554–561PubMed
29.
Zurück zum Zitat Zheng M, Deshpande S et al (2001) Contribution of vascular endothelial growth factor in the neovacularization process during the pathogenesisof herpetic stromal keratitis. J Virol 75:9828–9835PubMed Zheng M, Deshpande S et al (2001) Contribution of vascular endothelial growth factor in the neovacularization process during the pathogenesisof herpetic stromal keratitis. J Virol 75:9828–9835PubMed
30.
Zurück zum Zitat Zheng M, Schwarz MA et al (2001) Control of stromal keratits by inhibition of neovascularization. Am J Pathol 159:1021–1029PubMed Zheng M, Schwarz MA et al (2001) Control of stromal keratits by inhibition of neovascularization. Am J Pathol 159:1021–1029PubMed
Metadaten
Titel
HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9
verfasst von
Kozaburo Hayashi
Laura C. Hooper
Barbara Detrick
John J. Hooks
Publikationsdatum
01.02.2009
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 2/2009
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0303-7

Weitere Artikel der Ausgabe 2/2009

Archives of Virology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.